Autoantibodies Signal Reduced Cancer Risk in Dermatomyositis

In patients with dermatomyositis positive for anti-TIF1-γ autoantibodies, the presence of anti-CCAR1 autoantibodies indicate normal rather than elevated cancer risk.
Medscape Medical News

source https://www.medscape.com/viewarticle/988424?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?